Brown adipose tissue: from thermal physiology to bioenergetics

Chchd10 is dispensable for myogenesis but critical for adipose browning

The Chchd10 gene encodes a coiled-coil-helix-coiled-coil-helix-domain containing protein predicted to function in the mitochondrion and nucleus. Mutations of Chchd10 are associated with ALS, dementia and myopathy in humans and animal models, but how knockout of Chchd10 (Chchd10^KO) affects various tissues especially skeletal muscle and adipose tissues remains unclear. Here we show that Chchd10 expression increases as myoblasts and preadipocytes differentiate. During myogenesis, CHCHD10 interacts with TAR DNA binding protein 43 (TDP-43) in regenerating myofibers in vivo and in newly differentiated myotubes ex vivo. Surprisingly, Chchd10^KO mice had normal skeletal muscle development, growth and regeneration, with moderate defects in grip strength and motor performance. Chchd10^KO similarly had no effects on development of brown and white adipose tissues (WAT). However, Chchd10^KO mice had blunted response to acute cold and attenuated cold-induced browning of WAT, with markedly reduced UCP1 levels. Together, these results demonstrate that Chchd10 is dispensable for normal myogenesis and adipogenesis but is required for normal motility and cold-induced, mitochondrion-dependent browning of adipocytes. The data also suggest that human CHCHD10 mutations cause myopathy through a gain-of-function mechanism.

Contributors to Metabolic Disease Risk Following Spinal Cord Injury

Spinal cord injury (SCI) induced changes in neurological function have significant impact on the metabolism and subsequent metabolic-related disease risk in injured individuals. This metabolic-related disease risk relationship is differential depending on the anatomic level and severity of the injury, with high level anatomic injuries contributing a greater risk of glucose and lipid dysregulation resulting in type 2 diabetes and cardiovascular disease risk elevation. Although alterations in body composition, particularly excess adiposity and its anatomical distribution in the visceral depot or ectopic location in non-adipose organs, is known to significantly contribute to metabolic disease risk, changes in fat mass and fat-free mass do not fully account for this elevated disease risk in subjects with SCI. There are other negative adaptations in body composition including reductions in skeletal muscle mass and alterations in muscle fiber type, in addition to significant reduction in physical activity, that contribute to a decline in metabolic rate and increased metabolic disease risk following SCI. Recent studies in adult humans suggest cold- and diet-induced thermogenesis through brown adipose tissue metabolism may be important for energy balance and substrate metabolism, and particularly sensitive to sympathetic nervous signaling. Considering the alterations that occur in the autonomic nervous system (SNS) (sympathetic and parasympathetic) following a SCI, significant dysfunction of brown adipose function is expected. This review will highlight metabolic alterations following SCI and integrate findings from brown adipose tissue studies as potential new areas of research to pursue.

Thermogenesis and physiological maturity in neonatal lambs: a unifying concept in lamb survival

Lamb mortality represents reproductive wastage and an animal welfare concern. While lambs are thought to be at a thermogenic advantage following birth in comparison to other species, death from exposure can still be a major contributor to lamb mortality, largely because of the inclement conditions often prevailing at lambing. For this reason, thermogenesis has been studied extensively in neonatal lambs. Heat is produced in the neonatal lamb by shivering and non-shivering thermogenesis. The latter is heat generated by metabolism of brown adipose tissue (BAT) found largely in the thorax and peri-renal areas of the newborn lamb. Brown adipose tissue differs from normal adipose tissue in that it contains densely packed mitochondria, a high cytochrome c content and a vast vascular network. Heat is generated in BAT by uncoupling of the proton conductance mechanism from ATP production, resulting in heat production instead of stored energy. The ability of lambs to resist cooling differs among individuals and this is likely to be due to both genetic and phenotypic factors. The heritability of cold resistance is moderate-to-high and polymorphic gene markers associated with energy homeostasis and cold-related mortality have been identified. Additionally, several aspects of the phenotype of the lamb have been associated with cold resistance. Most relate to properties of the coat, skin and bodyweight, the latter being particularly important, presumably through effects on surface area to volume ratios and subsequent heat loss. The ability of the neonate to achieve the transition from intra- to extra-uterine life has been termed physiological maturity and is associated with the ability to activate appropriate neuro-endocrinological and behavioural changes that are consistent with homeostasis of energy metabolism. Ways to alter physiological maturity of the lamb, such as nutrition, pharmacology and genetic selection, have been identified, and while these show promising results with regards to thermoregulation, a key limitation of their application has been the lack of a repeatable, representative model of neonatal cold stress. An estimation of the non-shivering component potential of a lamb’s ability to thermoregulate can be derived from norepinephrine challenges, but more useful models of real-world cold stress are climate chambers or controlled water bath tests. Further use of repeatable test models such as these with appropriate neuroendocrine and metabolic metrics will identify key components and markers of physiological maturity associated with lamb thermogenesis and survival.

Variation in physiological profiles may explain breed differences in neonatal lamb thermoregulation

Ability to adapt rapidly from the uterine environment to self-thermoregulation following birth is a vital requirement for neonatal lamb survival. This investigation reports factors that could explain differences in thermoregulation among breeds that differ in lamb survival. Breeds such as the Merino and Border Leicester have previously been shown to be divergent for birthweight, cold resistance and lamb survival. Cross-bred (Poll Dorset Border Leicester (PDBL, n = 9) and Poll Dorset Merino (PDM, n = 25)) and pure-bred (Border Leicester (BL, n = 35) and Merino (M, n = 46)) lambs were recorded for the thermogenic measures rectal temperature at birth, cold resistance (time for rectal temperature to fall to 35°C while in a cooled water bath) and cold recovery (time to restore rectal temperature after cold exposure) at 1 day of age. In pure-bred lambs, 1 kg increase in weight resulted in a 0.25°C increase in rectal temperature at birth (P < 0.001) and 4.2 min increase in cold resistance (P < 0.001). In contrast, cross-bred lambs did not exhibit any relationship between birthweight and rectal temperature at birth, although they displayed a 3.2 min greater cold resistance for every 1 kg increase in birthweight (P < 0.001). BL-derived lambs were more cold resistant than M lambs (cross-bred: PDBL, 67.1 ± 2.5 min; PDM, 56.4 ± 1.6 min; P < 0.01; and pure-bred: BL, 58.1 ± 1.5 min; M, 53.2 ± 1.3 min; P < 0.01). The quadratic relationship of glucose concentration over time during cold exposure differed with lamb breed. PDBL exhibited higher peak glucose concentrations than did PDM (11.0 mmol/L and 8.9 mmol/L, respectively; P < 0.01). BL took longer to reach peak glucose concentration (50 min) than did M (40 min) and this peak value was higher (BL, 9.4 mmol/L; M, 7.7 mmol/L; P < 0.001). In conclusion, variations in birthweight and glucose metabolism are associated with breed differences in thermogenesis of neonatal lambs.

Candida albicans and selenium

Although low selenium levels have been recorded in infants, no specific human disorder has been linked to low selenium status. The incidence of thrush, the common enteric fungal infection caused by Candida albicans, has increased markedly with antibiotic therapy and research has provided evidence that its colonization leads to competition for Coenzyme Q10 (CoQ10) in the host. Furthermore it is now known that ubiquinones are essential in heart muscle for oxidative phosphorylation in the mitochondrial respiratory chain and considered that glutathione peroxidase (GSHPx) in the mitochondria protects ubiquinone from oxidation.

The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance

The corticotropin-releasing factor (CRF) system could play a significant role in the regulation of energy balance. This system, which includes CRF, CRF-related peptides and CRF receptors, is part of a huge network of cells connected to central and peripheral pathways modulating energy metabolism. CRF and CRF-related peptides, which elicit their effects through G-protein-coupled receptors known in mammals as CRF(1) receptor and CRF(2) receptor, are capable of strong anorectic and thermogenic effects. Also supporting a role for the CRF system in the regulation of energy balance are findings demonstrating alterations in this system in obese and food-deprived animals that concur to facilitate energy deposition. In recent years, great progress has been made in understanding the specific physiological roles of the CRF system. In that respect, the discovery of urocortins II and III, two endogenous ligands of the CRF(2) receptor, and the development of selective and long-acting antagonists for the CRF receptors, have led to a better comprehension of the role of the CRF system in the regulation of energy balance. Although there are still important unresolved issues in the field of CRF research, the progress made recently warrants investigations aimed at evaluating the CRF system as a potential target for anti-obesity drugs.

The effects of topiramate and sex hormones on energy balance of male and female rats

OBJECTIVE

The effects of topiramate (TPM) on components of energy balance were tested in male and female rats that were (i) left intact, (ii) castrated or (iii) castrated with replacement therapies consisting of testosterone administration in orchidectomized (OCX) rats and of estradiol or progesterone treatments in ovariectomized (OVX) rats.

METHODS

TPM was mixed into the diet and administered at a dose of 60 mg per kg of body weight. Male and female rats were treated for 28 and 35 days, respectively. At the end of the treatment period, variables of energy balance and determinants of lipid and glucose metabolism were assessed.

RESULTS

TPM reduced energy and fat gains in both male and female rats either in the absence or in the presence of hormone replacement therapies. In male rats, it also decreased food intake, protein gain and energetic efficiency. In female animals, TPM reduced energetic efficiency while it stimulated lipoprotein lipase activity in brown adipose tissue. TPM also reduced plasma glucose and plasma leptin levels in female rats as well as plasma insulin and liver triglycerides in male animals. As expected, castration and sex hormones also strongly influenced energy balance. In male rats, OCX led to a decrease in energy and protein gains that was blocked by treatment with testosterone. In female rats, OVX caused increases in energy, fat and protein gains that were prevented by treatment with estradiol.

CONCLUSION

In female rats, the effects of TPM on fat and energy gains were clearly not influenced by the sex hormone status of the rats. In male animals, there was also no interaction of TPM and the status of sex hormones on energy balance, suggesting that OCX and testosterone minimally interfere with the action of TPM on energy balance. The effects of TPM on energy balance were accounted for by a decrease in energetic efficiency, resulting from an effect exerted by the drug on both energy intake and thermogenesis. The present results also suggest that TPM can enhance insulin sensitivity.

Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor

The abnormalities of lipid metabolism observed in cancer cachexia may be induced by a lipid-mobilizing factor produced by adenocarcinomas. The specific molecules and metabolic pathways that mediate the actions of lipid-mobilizing factor are not known. The mitochondrial uncoupling proteins-1, -2 and -3 are suggested to play essential roles in energy dissipation and disposal of excess lipid. Here, we studied the effects of lipid-mobilizing factor on the expression of uncoupling proteins-1, -2 and -3 in normal mice. Lipid-mobilizing factor isolated from the urine of cancer patients was injected intravenously into mice over a 52-h period, while vehicle was similarly given to controls. Lipid-mobilizing factor caused significant reductions in body weight (-10%, P=0.03) and fat mass (-20%, P<0.01) accompanied by a marked decrease in plasma leptin (-59%, P<0.01) and heavy lipid deposition in the liver. In brown adipose tissue, uncoupling protein-1 mRNA levels were elevated in lipid-mobilizing factor-treated mice (+96%, P<0.01), as were uncoupling proteins-2 and -3 (+57% and +37%, both P<0.05). Lipid-mobilizing factor increased uncoupling protein-2 mRNA in both skeletal muscle (+146%, P<0.05) and liver (+142%, P=0.03). The protein levels of uncoupling protein-1 in brown adipose tissue and uncoupling protein-2 in liver were also increased with lipid-mobilizing factor administration (+49% and +67%, both P=0.02). Upregulation by lipid-mobilizing factor of uncoupling proteins-1, -2 and -3 in brown adipose tissue, and of uncoupling protein-2 in skeletal muscle and liver, suggests that these uncoupling proteins may serve to utilize excess lipid mobilized during fat catabolism in cancer cachexia.

Influence of topiramate in the regulation of energy balance

Topiramate (TPM) is a novel neurotherapeutic agent currently indicated for the treatment of epilepsy and undergoing development for other central nervous system indications including neuropathic pain, bipolar disorder, and migraine prophylaxis. TPM is synthesized from D-fructose and contains a sulfamate moiety that is essential for its pharmacologic activity. TPM has been observed to significantly reduce body weight in patients treated for seizure, which has prompted the realization of preclinical studies to characterize the effects of TPM in the regulation of energy balance. Studies carried out in various strains of rats have provided good evidence for the ability of TPM to blunt energy deposition. Body composition analyses from rat trials have demonstrated that TPM inhibits fat deposition while reducing the activity of lipoprotein lipase (LPL) in various white adipose tissue depots. High doses of TPM (likely above the therapeutic dose range) have also been observed to reduce protein gain without catabolic effects. Although TPM cannot be described as a potent anorectic agent, it seems to have the ability to reduce food intake; significant reductions in food intake have been observed in female obese (fa/fa) Zucker rats and in female Wistar rats. TPM can also reduce energy deposition in the absence of alterations in food intake. This effect has been clearly emphasized in female lean (Fa/?) Zucker rats. In female Sprague-Dawley rats, TPM also increased energy expenditure and it has been observed to increase LPL activity in brown adipose tissue, which could indicate that TPM has the ability to enhance regulatory thermogenesis. In addition, TPM stimulates LPL activity in skeletal muscles, further emphasizing its potential to promote substrate oxidation. The mechanisms whereby TPM affects the regulation of energy balance have yet to be understood. TPM represents an antiepileptic drug (AED) with complex biochemical/pharmacologic actions. Its negative effects on energy deposition cannot be readily predicted from these actions, as AEDs are generally expected to stimulate body weight gain. Recent data, obtained from investigations aimed at assessing the effects of TPM on neuropeptidergic systems involved in the regulation of energy balance, have failed to demonstrate any significant effects of TPM on the neuropeptide Y and proopiomelanocortin systems. In conclusion, it is clear that TPM can reduce fat deposition by either reducing food intake or stimulating energy expenditure. The mechanisms whereby an AED such as TPM controls food intake and energy expenditure remains to be delineated. Copyright1999 ASCRS and ESCRS

The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones

The antihypertensive agent moxonidine, an imidazoline Ii-receptor agonist, also induces hypophagia and lowers body weight in the obese spontaneously hypertensive rat, but the central mediation of this action and the neuronal pathways that moxonidine may interact with are not known. We studied whether moxonidine has anti-obesity effects in the genetically-obese and insulin-resistant fa/fa Zucker rat, and whether these are mediated through inhibition of the hypothalamic neuropeptide Y (NPY) neurones. Lean and obese Zucker rats were given moxonidine (3 mg kg(-1) day(-1)) or saline by gavage for 21 days. Moxonidine decreased food intake throughout by 20% in obese rats (P<0.001) and by 8% in lean rats (P<0.001), and reduced weight gain that final body weight was 15% lower in obese (P<0.001) and 7% lower in lean (P<0.01) rats than their untreated controls. Plasma insulin and leptin levels were decreased in moxonidine-treated obese rats (P<0.01 and P<0.05), but unchanged in treated lean rats. Uncoupling protein-1 gene expression in brown adipose tissue was stimulated by 40-50% (P< or =0.05) in both obese and lean animals given moxonidine. Obese animals given moxonidine showed a 37% reduction in hypothalamic NPY mRNA levels (P = 0.01), together with significantly increased NPY concentrations in the paraventricular nucleus (P<0.05), but no changes in the arcuate nucleus or other nuclei; this is consistent with reduced NPY synthesis in the arcuate nucleus and blocked release of NPY in the paraventricular nucleus. In lean animals, moxonidine did not affect NPY levels or NPY mRNA. The hypophagic, thermogenic and anti-obesity effects of moxonidine in obese Zucker rats may be partly due to inhibition of the NPY neurones, whose inappropriate overactivity may underlie obesity in this model.

Effect of 12, 24 and 72 hours fasting in thermogenic parameters of rat brown adipose tissue mitochondrial subpopulations

The aim of the present work was to study the effects of various durations of fasting (12, 24 and 72 hours) on brown adipose tissue (BAT) thermogenic parameters--cytrochrome-c-oxidase (COX) activity, GDP-binding activity and uncoupling protein (UCP1) content--and also on morphological features of different mitochondrial subpopulations, obtained by differential centrifugation--M1 (1000 g), M3 (3000 g) and M15 (15,000 g) fractions. The mitochondrial subpopulations showed morphological differences and a different distribution of UCP1 levels and of GDP-binding in all experimental groups. Starvation induced a decrease in the average size for all mitochondrial subtypes. The main changes induced by fasting in thermogenic parameters were observed in the M15 subtype. After the first 24h of starvation, there was a significant decrease of UCP1 levels only in the lightest mitochondrial subpopulation. However, the 72h fasted situation reflected a tendency to increase UCP1 content and UCP1/COX ratio together with a significant decrease of GDP-binding/UCP1 ratio, thus indicating more masked GDP-binding sites. Important fasting-induced changes in both morphological and biochemical parameters in BAT mitochondrial subtypes reflect their role in the physiological response of BAT to starvation.

Ontogeny of thermoregulation in the Djungarian hamster (Phodopus campbelli)

At birth, altricial Djungarian hamster pups require exogenous heat to grow and gain little benefit from huddling with their littermates. By day 6 huddled pups begin effective thermogenesis although isolated pups do not show spontaneous increases in temperature until day 9. On day 12, isolated pups can resist cooling for short periods of time and huddles do not cool within a 15 min test. By day 15, isolated pups can thermoregulate, although at a lower core body temperature than is typical of adults, and both huddling contact with littermates and direct contact with the dam are reduced. At weaning, pups are effectively thermally independent. This ontogeny is correlated with behavioral, morphological and physiological changes during pup development including brown adipose tissue (BAT) thermogenesis, pelage development and body size. The onset of thermogenesis, and then thermoregulation, causes temporary reductions in pup growth rate on days 6 and 7 and again on days 12 and 13. Body weight, rather than pup age, appears critical for independent thermoregulation. These results are discussed relative to the extent of maternal hyperthermia and the physiological demands of the concurrent gestation characteristic of reproduction in Djungarian hamsters.

Sudden infant death syndrome (SIDS): disordered brown fat metabolism and thermogenesis

Foster found areas with the highest incidence of SIDS in USA in 1983-1984 coincided with the highest areas recorded with the highest incidence of goitre in First World War troops (1). Reid compared the two populations described as having the highest incidence of SIDS worldwide. Both were selenium deficient areas (King County WA, USA and Canterbury, New Zealand). Besides being a selenium livestock responsive area, Canterbury school children, prior to 1925, had a 56% incidence of goitre (2-6). Brown adipose tissue (BAT) synthesises fatty acids from glucose. BAT is a major tissue in fatty acid metabolism for the generation of heat (7). BAT has the specific property of converting thyroxine (T4) to triodothyronine (T3) via Type II deiodinase enzyme. There is a many fold increase in the activity of this deiodinase in BAT after exposure of rats to sudden cold, which is greatly impaired in selenium deficient animals (7). The accepted picture of SIDS worldwide is that there is an increased incidence in infants of young smoking mothers. The incidence peaks in the second and third month of life, in winter and as latitude increases.